In vitro evaluation of the metabolic enzymes and drug interaction potential of triapine

被引：0
|
作者：
Anand Joshi
Brian F. Kiesel
Nupur Chaphekar
Reyna Jones
Jianxia Guo
Charles A. Kunos
Sarah Taylor
Edward Chu
Raman Venkataramanan
Jan H. Beumer
机构：
[1] University of Pittsburgh,Department of Pharmaceutical Sciences, School of Pharmacy
[2] UPMC Hillman Cancer Center,Cancer Therapeutics Program
[3] National Cancer Institute,Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis
[4] University of Pittsburgh-Magee Women’s Hospital,Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Medicine
[5] University of Pittsburgh School of Medicine,Division of Hematology
[6] University of Pittsburgh,Oncology, Department of Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2020年 / 86卷
关键词：
Triapine; Metabolism; Drug–drug interaction; CYP450; Metabolic pathway;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：633 / 640
页数：7
相关论文
共 50 条
  • [21] Potential Interaction of Pinocembrin with Drug Transporters and Hepatic Drug-Metabolizing Enzymes
    Sangkapat, Sirima
    Boonnop, Rattiporn
    Pimta, Jeerawat
    Chabang, Napason
    Nutho, Bodee
    Jutabha, Promsuk
    Soodvilai, Sunhapas
    PHARMACEUTICALS, 2025, 18 (01)
  • [22] Fusidic Acid Inhibits Hepatic Transporters and Metabolic Enzymes: Potential Cause of Clinical Drug-Drug Interaction Observed with Statin Coadministration
    Gupta, Anshul
    Harris, Jennifer J.
    Lin, Jianrong
    Bulgarelli, James P.
    Birmingham, Bruce K.
    Grimm, Scott W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (10) : 5986 - 5994
  • [23] In vitro metabolic interaction studies: Experience of the Food and Drug Administration
    Yuan, R
    Parmelee, T
    Balian, JD
    Uppoor, RS
    Ajayi, F
    Burnett, A
    Lesko, LJ
    Marroum, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 66 (01) : 9 - 15
  • [24] In Vitro Evaluation of the Potential for Drug Interactions by Salidroside
    Kasprzyk, Philip G.
    Tremaine, Larry
    Fahmi, Odette A.
    Weng, Jing-Ke
    NUTRIENTS, 2023, 15 (17)
  • [25] Interaction Potential of Etravirine with Drug Transporters Assessed In Vitro
    Zembruski, Nadine Cecile Luise
    Haefeli, Walter Emil
    Weiss, Johanna
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (03) : 1282 - 1284
  • [26] In Vitro Assessment of Drug Interaction Potential of Licorice Extracts
    Tonsing-Carter, Alyssa
    Li, Guannan
    van Breemen, Richard
    FASEB JOURNAL, 2017, 31
  • [27] Drug-Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies
    Zurth, Christian
    Koskinen, Mikko
    Fricke, Robert
    Prien, Olaf
    Korjamo, Timo
    Graudenz, Kristina
    Denner, Karsten
    Bairlein, Michaela
    Von Buehler, Clemens-Jeremias
    Wilkinson, Gary
    Gieschen, Hille
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2019, 44 (06) : 747 - 759
  • [28] Toxicokinetics of β-Amanitin in Mice and In Vitro Drug-Drug Interaction Potential
    Bang, Young Yoon
    Song, Im-Sook
    Lee, Min Seo
    Lim, Chang Ho
    Cho, Yong-Yeon
    Lee, Joo Young
    Kang, Han Chang
    Lee, Hye Suk
    PHARMACEUTICS, 2022, 14 (04)
  • [29] Evaluation of the Clinical Drug-Drug Interaction Potential of Pritelivir on Transporters and CYP450 Enzymes Using a Cocktail Approach
    de Vries, Michiel
    Bonsmann, Susanne
    Pausch, Joerg
    Sumner, Melanie
    Birkmann, Alexander
    Zimmermann, Holger
    Kropeit, Dirk
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (07): : 755 - 769
  • [30] In Vitro Evaluation of Drug-Drug Interaction Potential of Epetraborole, a Novel Bacterial Leucyl-tRNA Synthetase Inhibitor
    Shafiee, Afshin
    Chanda, Sanjay
    PHARMACEUTICALS, 2024, 17 (01)
12345